Revance Therapeutics Inc

NASDAQ:RVNC  
24.72
+0.21 (+0.86%)
Other Pre-Announcement

Revance Reports Q3 2020 Financial Results

Published: 11/09/2020 22:26 GMT
Revance Therapeutics Inc (RVNC) - Revance Reports Third Quarter 2020 Financial Results and Provides Corporate Update.
Revenue for Quarter Ended September 30, 2020 Was $3.8 Million Compared to $46 Thousand.
Q3 Revenue View $1.8 Million -- Refinitiv Ibes Data (analyst estimates).
Qtrly Loss per Share $1.34.
Q3 Earnings per Share View $-1.03 -- Refinitiv Ibes Data (analyst estimates).